NSE BSE
nifty pharma

Nifty Pharma

- - (%)
Sector: -

26084

Nifty Pharma

img img img img
No Data Available

Nifty Pharma Performance

Day Range

Low19094.35 High19256.85
19120.65

52 Week Range

Low 12325.80 High 19422.20
19120.65

Open Price

19252.15

Prev. Close

19216.35

Volume (Shares)

.00

Total traded value

.00

Upper Circuit

.00

Lower Circuit

.00

Companies

COMPANY CURRENT PRICE OPEN PRICE CLOSE PRICE CHANGE %

    

An Overview

The pharmaceutical sector is one of the most important and dynamic sectors in the Indian economy. It contributes to the health and well-being of millions of people, both in India and abroad. It also provides employment opportunities, exports, and innovation. In this blog post, we will take a look at the Nifty Pharma Index, which captures the performance of the pharmaceutical sector in India.

 

What is the Nifty Pharma Index?

The Nifty Pharma Index is an index that tracks the performance of 20 companies listed on the National Stock Exchange of India (NSE) that are engaged in the pharmaceutical business. The index was launched on January 1, 2001, with a base value of 1000.

 

The free float market value is the product of the total number of shares and the price of each share. The free float market value excludes the shares held by the promoters, government, strategic investors, and other locked-in shares that will not be traded in the normal course. The index is rebalanced semi-annually, in January and July, to ensure that it reflects the current market conditions and composition of the sector.

 

Why is the Nifty Pharma Index important?

The Nifty Pharma Index is important because it provides a benchmark for the performance of the pharmaceutical sector in India. It can be used for a variety of purposes, such as:

 

  • Launching of index funds, ETFs, and structured products: Index funds, exchange-traded funds (ETFs), and structured products are financial instruments that replicate the performance of an underlying index. By launching such products based on the Nifty Pharma Index, investors can gain exposure to the pharmaceutical sector in India without having to buy individual stocks. This can reduce the transaction costs, diversify the risk, and provide liquidity.

  • Research and analysis: Researchers and analysts can use the index to study the trends, patterns, and drivers of the pharmaceutical sector in India. They can also use the index to identify the opportunities and challenges faced by the sector and its constituents.

 

What are the factors that affect the Nifty Pharma Index?

The Nifty Pharma Index is affected by various factors, both internal and external, that influence the performance of the pharmaceutical sector in India. Some of the key factors are:

 

  • Regulatory environment: The pharmaceutical sector in India is regulated by various authorities, such as the Central Drugs Standard Control Organization (CDSCO), the Drug Controller General of India (DCGI), the National Pharmaceutical Pricing Authority (NPPA), the Department of Pharmaceuticals (DoP), and the Ministry of Health and Family Welfare (MoHFW). These authorities set the standards, guidelines, and policies for the approval, manufacturing, pricing, marketing, and distribution of drugs in India. Any changes in the regulatory environment can have a significant impact on the operations, profitability, and competitiveness of the pharmaceutical companies in India.

  • Research and development: The pharmaceutical sector in India is driven by research and development (R&D) activities that aim to discover, develop, and launch new and innovative drugs in the market. R&D activities require substantial investments, time, and resources, and involve a high degree of uncertainty and risk. The success or failure of R&D activities can affect the growth, reputation, and market share of the pharmaceutical companies in India.

  • Competition: The pharmaceutical sector in India faces intense competition from both domestic and international players. The domestic players compete on the basis of price, quality, product portfolio, distribution network, and customer loyalty. The international players compete on the basis of technology, innovation, branding, and patents. The competition can affect the pricing, margins, and market share of the pharmaceutical companies in India.

  • Demand and supply: The demand and supply of drugs in India are influenced by various factors, such as the population, income, health awareness, disease prevalence, government policies, insurance coverage, and consumer preferences. The demand and supply of drugs can also be affected by external factors, such as the global pandemic, natural disasters, geopolitical tensions, and trade barriers. The demand and supply of drugs can affect the revenue, profitability, and inventory of the pharmaceutical companies in India.

 

Wrapping Up

The Nifty Pharma Index is a comprehensive and representative index that reflects the performance of the pharmaceutical sector in India. The index provides a useful tool for investors, fund managers, researchers, and analysts to gain insights into the sector and its constituents. The index is also a reflection of the opportunities and challenges faced by the sector in the dynamic and competitive environment. The index is expected to continue to evolve and adapt to the changing needs and expectations of the stakeholders in the sector.

 

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory. 

 

Click Here For Research Disclaimers: https://bit.ly/3Tcsfuc

All Indices

  • NSE
  • BSE
NAME PRICE CHANGE CHANGE % PREVIOUS CLOSE
NAME PRICE CHANGE CHANGE % PREVIOUS CLOSE

Frequently Asked Questions

Is investing in the Nifty Pharma Index a good idea for beginners?

Answer Field

The Nifty Pharma Index is an index that tracks the performance of the pharmaceutical sector in India. It comprises 15 stocks that are listed on the National Stock Exchange (NSE) and have a high correlation with the global metals prices. Investing in the Nifty Pharma Index can provide exposure to the growth potential of the Indian pharmaceutical industry, which is expected to benefit from the increasing demand for healthcare products and services, both domestically and globally. However, investing in the Nifty Pharma Index also involves some risks, such as:

  • High volatility: The Nifty Pharma Index can be affected by various factors, such as regulatory changes, patent expiries, product approvals, pricing pressures, currency fluctuations, and competition. These factors can cause significant fluctuations in the index value, which can impact the returns of the investors.

  • Sector concentration: The Nifty Pharma Index is a sector-specific index, which means it does not offer diversification across different sectors or industries. Investing in a single sector can expose the investors to the sector-specific risks, which can be higher than the market risks.

  • Tracking error: The Nifty Pharma Index is a passive index, which means it does not actively manage its portfolio or adjust to the changing market conditions. The index funds or ETFs that track the Nifty Pharma Index may not be able to replicate the exact performance of the index, due to various factors, such as fees, expenses, liquidity, and rebalancing⁵. This can result in a tracking error, which is the difference between the returns of the index fund or ETF and the returns of the index.

Therefore, investing in the Nifty Pharma Index may not be a good idea for beginners, unless they have a high risk appetite, a long-term investment horizon, and a thorough understanding of the pharmaceutical sector. Beginners may be better off investing in diversified equity funds or index funds that track broader indices, such as the Nifty 50 or the Nifty 500, which can offer lower volatility, higher diversification, and lower tracking error.

 

How can I buy shares in companies listed on the Nifty Pharma Index?

Answer Field

There are two ways to buy shares in companies listed on the Nifty Pharma Index:

  • Directly: You can buy the individual shares of the companies that constitute the Nifty Pharma Index, through a stock broker or a trading platform. You will need a demat account and a trading account to do so. You will also have to pay brokerage fees, transaction charges, and taxes on your trades. You will have to monitor the performance of each company and decide when to buy or sell the shares. You will also have to bear the risk of selecting the right companies and timing the market.

  • Indirectly: You can buy an index fund or an ETF that tracks the Nifty Pharma Index, through a mutual fund house or an exchange. You will need a demat account and a trading account to do so. You will also have to pay management fees, expense ratio, and taxes on your investments. You will not have to worry about selecting the individual companies or timing the market, as the index fund or ETF will do that for you. You will also benefit from the diversification and lower tracking error of the index fund or ETF.

Can I invest in the Nifty Pharma Index through a mutual fund?

Answer Field

Yes, you can invest in the Nifty Pharma Index through a mutual fund. There are two types of mutual funds that can help you invest in the Nifty Pharma Index:

  • Index funds: These are mutual funds that invest in the same stocks and in the same proportion as the Nifty Pharma Index. They aim to replicate the performance of the index, subject to tracking error. They have low management fees, low expense ratio, and low turnover ratio. They are suitable for passive investors who want to invest in the pharmaceutical sector without taking active bets on individual companies or market movements. An example of an index fund that tracks the Nifty Pharma Index is the ICICI Prudential Nifty Pharma Index Fund.

  • Sectoral funds: These are mutual funds that invest in the pharmaceutical sector, but not necessarily in the same stocks or in the same proportion as the Nifty Pharma Index. They aim to outperform the index by taking active bets on individual companies or market movements. They have higher management fees, higher expense ratio, and higher turnover ratio. They are suitable for active investors who have a high risk appetite, a high conviction, and a deep knowledge of the pharmaceutical sector. An example of a sectoral fund that invests in the pharmaceutical sector is the Nippon India Pharma Fund.

Can I use the Nifty Pharma Index to plan for retirement?

Answer Field

The Nifty Pharma Index can be used to plan for retirement, but only as a part of a diversified portfolio that includes other asset classes, such as debt, gold, and real estate. The Nifty Pharma Index can provide long-term capital appreciation, as the pharmaceutical sector is expected to grow at a faster rate than the overall economy, due to the rising demand for healthcare products and services, both domestically and globally. However, the Nifty Pharma Index also has some drawbacks, such as:

  • High volatility: The Nifty Pharma Index can be affected by various factors, such as regulatory changes, patent expiries, product approvals, pricing pressures, currency fluctuations, and competition³. These factors can cause significant fluctuations in the index value, which can impact the returns of the investors. This can be detrimental for retirement planning, as it can erode the value of the corpus and affect the ability to meet the retirement goals.
  • Sector concentration: The Nifty Pharma Index is a sector-specific index, which means it does not offer diversification across different sectors or industries. Investing in a single sector can expose the investors to the sector-specific risks, which can be higher than the market risks. This can be risky for retirement planning, as it can increase the chances of losing money and reduce the chances of achieving the desired returns.
  • Tracking error: The Nifty Pharma Index is a passive index, which means it does not actively manage its portfolio or adjust to the changing market conditions. The index funds or ETFs that track the Nifty Pharma Index may not be able to replicate the exact performance of the index, due to various factors, such as fees, expenses, liquidity, and rebalancing. This can result in a tracking error, which is the difference between the returns of the index fund or ETF and the returns of the index. This can be harmful for retirement planning, as it can reduce the returns and increase the uncertainty of the outcome.

    Therefore, the Nifty Pharma Index can be used to plan for retirement, but only as a part of a diversified portfolio that includes other asset classes, such as debt, gold, and real estate. The Nifty Pharma Index can provide long-term capital appreciation, but it also has high volatility, sector concentration, and tracking error. The investors should have a high risk appetite, a long-term investment horizon, and a thorough understanding of the pharmaceutical sector. The investors should also monitor the performance of the index and rebalance their portfolio periodically, to maintain the desired asset allocation and risk-return profile.

What are the top-performing pharmaceutical companies in the Nifty Pharma Index?

Answer Field

According to the web search results, the top-performing pharmaceutical companies in the Nifty Pharma Index, based on the one-year returns as of December 20, 2023, are:

  • Pfizer Ltd: This company is a subsidiary of the global pharmaceutical giant Pfizer Inc. It is engaged in the manufacturing, marketing, and distribution of various pharmaceutical products, such as vaccines, antibiotics, anti-infectives, cardiovascular, and oncology drugs. It has a market capitalization of Rs. 19,376 crore and a one-year return of 26.08%.

  • Aurobindo Pharma Ltd: This company is one of the largest generic drug manufacturers in India. It is involved in the production and export of various pharmaceutical products, such as active pharmaceutical ingredients (APIs), formulations, biosimilars, and over-the-counter (OTC) products. It has a market capitalization of Rs. 60,510 crore and a one-year return of 18%.

  • Cipla Ltd: This company is one of the leading pharmaceutical companies in India. It is engaged in the development and manufacture of various pharmaceutical products, such as respiratory, urology, anti-retroviral, anti-diabetic, and anti-malarial drugs. It has a market capitalization of Rs. 99,825 crore and a one-year return of 16.67%.

  • Sun Pharmaceutical Industries Ltd: This company is the largest pharmaceutical company in India by market capitalization. It is involved in the manufacture and sale of various pharmaceutical products, such as generics, branded generics, specialty, and over-the-counter (OTC) products. It has a market capitalization of Rs. 2,98,837 crore and a one-year return of 11.67%.

  • Dr. Reddy's Laboratories Ltd: This company is one of the major pharmaceutical companies in India. It is engaged in the research and development, production, and marketing of various pharmaceutical products, such as generics, biosimilars, differentiated formulations, and new chemical entities (NCEs). It has a market capitalization of Rs. 94,044 crore and a one-year return of 10.67%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text